Silverback Therapeutics, Inc. (NASDAQ:SBTX – Get Free Report) hit a new 52-week high on Tuesday . The stock traded as high as $15.61 and last traded at $15.32, with a volume of 574261 shares changing hands. The stock had previously closed at $15.20.
Silverback Therapeutics Stock Up 0.8 %
The stock has a 50 day moving average of $13.90 and a 200 day moving average of $11.21. The firm has a market cap of $552.41 million, a price-to-earnings ratio of -6.28 and a beta of 0.60.
About Silverback Therapeutics
Silverback Therapeutics, Inc, a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.
Featured Articles
- Five stocks we like better than Silverback Therapeutics
- 3 Small Caps With Big Return Potential
- Palantir Cracks $50, Is There Still Time to Get on Board?
- How to Find Undervalued Stocks
- Insider Buying Signals Upside for These 3 Stocks
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Receive News & Ratings for Silverback Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silverback Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
